(Q44775955)

English

Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study. French Multicenter Study Group

scientific article published in June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study. French Multicenter Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

X Causse

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J L Payen

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J Izopet

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

G Babany

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M F Girardin

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1003-1010

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain. Hepatitis HIV Spanish Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

CLINICAL CALORIMETRY

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predictive of the response to interferon in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980105-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(00)80105-1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44775955&oldid=2040314571"